ARCHIVES

FDA Rile Changes Reporting Requirements for Adverse Events

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

Pregnancy-Associated Breast Cancer More Likely Diagnosed At Advanced Stage

February 27, 2009

Standard Procedures Discarded in Review Of $20 Million in Texas Funds For Project Led by Wife of MD Anderson President

May 25, 2012

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

ASCO President Criticizes Use Of Cooperative Agreement in Clinical Trials

May 18, 1984

Older Patients Can Do Well With Stem Cell Transplants

March 30, 2007

In Brief: Ahoy! It’s “Admiral Rick”

April 2, 1999